Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer
Open Access
- 18 February 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 91 (3) , 349-354
- https://doi.org/10.1002/bjs.4389
Abstract
Background: The aim of this study was to identify patient and tumour characteristics that might assist in developing an improved approach to patient selection for chemotherapy after resection of clinicopathological stage C colonic cancer. Methods: Clinical, pathological and follow-up data have been collected prospectively for all patients undergoing resection for colorectal cancer at Concord Hospital since 1971. From an initial 2980 patients, after exclusions 378 remained who had a potentially curative operation for colonic cancer with nodal metastases and did not receive adjuvant chemotherapy. Associations between several pathological features and survival were examined by proportional hazards regression. Results: In a multivariate model, both overall and colonic cancer-specific survival rates were negatively associated with serosal surface involvement, apical node metastasis, high histological grade and venous invasion. The survival of patients with stage C disease who had none of these adverse features was not significantly different from that of patients with stage B lesions. However, survival diminished significantly when one or more of the adverse features were present. Conclusion: Patients with a stage C tumour but with none of the identified adverse features experience relatively good survival and are unlikely to benefit from adjuvant chemotherapy. In this series such patients accounted for 40·5 per cent of patients with stage C disease.Keywords
This publication has 17 references indexed in Scilit:
- DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular studyPublished by Elsevier ,2002
- Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable PrognosisThe American Journal of Pathology, 2001
- Prognostic significance of K- ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with dukes C colon cancerDiseases of the Colon & Rectum, 2001
- A Systematic Overview of Chemotherapy Effects in Colorectal CancerActa Oncologica, 2001
- Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancerBritish Journal of Surgery, 2000
- Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trialThe Lancet, 2000
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000
- p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon CarcinomaOncology, 2000
- Mismatch repair proficiency and in vitro response to 5-fluorouracilGastroenterology, 1999
- Is there a standard adjuvant treatment for colon cancer?European Journal Of Cancer, 1998